Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
15.35
+0.03 (0.20%)
Dec 5, 2025, 3:00 PM CST
5.72% (1Y)
| Market Cap | 22.93B |
| Revenue (ttm) | 8.35B |
| Net Income (ttm) | 1.10B |
| Shares Out | 1.49B |
| EPS (ttm) | 0.74 |
| PE Ratio | 20.76 |
| Forward PE | 13.18 |
| Dividend | 0.53 (3.46%) |
| Ex-Dividend Date | Oct 17, 2025 |
| Volume | 6,585,660 |
| Average Volume | 9,326,448 |
| Open | 15.37 |
| Previous Close | 15.32 |
| Day's Range | 15.18 - 15.37 |
| 52-Week Range | 13.51 - 17.69 |
| Beta | 0.39 |
| RSI | 41.72 |
| Earnings Date | Feb 24, 2026 |